Altunisik E[au] - Search Results

Year	Number of Results
2016	2
2019	1
2020	1
2021	8
2022	4

1

Neurological symptoms in COVID-19 patients.

Altunisik E, Sayiner HS, Aksoz S, Cil E, Ozgenc G. Altunisik E, et al. Bratisl Lek Listy. 2021;122(1):39-44. doi: 10.4149/BLL_2021_004. Bratisl Lek Listy. 2021. PMID: 33393319

2

Feed-forward LPQNet based Automatic Alzheimer's Disease Detection Model.

Kaplan E, Dogan S, Tuncer T, Baygin M, Altunisik E. Kaplan E, et al. Among authors: altunisik e. Comput Biol Med. 2021 Oct;137:104828. doi: 10.1016/j.compbiomed.2021.104828. Epub 2021 Sep 4. Comput Biol Med. 2021. PMID: 34507154

3

Quantitative Analysis of the Olfactory System in COVID-19: An MR Imaging Study.

Altunisik E, Baykan AH, Sahin S, Aydin E, Erturk SM. Altunisik E, et al. AJNR Am J Neuroradiol. 2021 Dec;42(12):2207-2214. doi: 10.3174/ajnr.A7278. Epub 2021 Sep 23. AJNR Am J Neuroradiol. 2021. PMID: 34556477 Free PMC article.

4

Is Increased Intracranial Pressure a Factor in Persistent Headache After Coronavirus Disease 2019?

Altunisik E, Sut SK, Sahin S, Baykan AH. Altunisik E, et al. J Nerv Ment Dis. 2021 Sep 1;209(9):640-644. doi: 10.1097/NMD.0000000000001393. J Nerv Ment Dis. 2021. PMID: 34280176 Free PMC article.

5

Effect of omalizumab treatment on peripheral nerves in patients with chronic spontaneous urticaria.

Altunisik E, Inan Dogan E. Altunisik E, et al. Cutan Ocul Toxicol. 2021 Jun;40(2):130-134. doi: 10.1080/15569527.2021.1914076. Epub 2021 Apr 26. Cutan Ocul Toxicol. 2021. PMID: 33902373 Clinical Trial.

6

Does levetiracetam use affect Visual Evoked Potentials (VEP) in the treatment of childhood epilepsy?

Aydin H, Bucak IH, Altunisik E. Aydin H, et al. Among authors: altunisik e. Minerva Pediatr (Torino). 2021 Apr 2. doi: 10.23736/S2724-5276.21.05879-1. Online ahead of print. Minerva Pediatr (Torino). 2021. PMID: 33820402

7

Retinal Neurovascular Structural Changes in Optical Coherence Tomography and the Relationship between These Changes and White Matter Hyperintensities in Patients with Migraine.

Altunisik E, Oren B. Altunisik E, et al. Eur Neurol. 2021;84(6):460-471. doi: 10.1159/000518380. Epub 2021 Aug 30. Eur Neurol. 2021. PMID: 34515117

8

Quantitative analysis of healthy olfactory sulcus depth, olfactory tract length and olfactory bulb volume in the paediatric population: a magnetic resonance study.

Sahin S, Baykan AH, Altunisik E, Vural CA, Sahin FD, Inan I. Sahin S, et al. Among authors: altunisik e. Folia Morphol (Warsz). 2021;80(1):33-39. doi: 10.5603/FM.a2020.0125. Epub 2020 Oct 21. Folia Morphol (Warsz). 2021. PMID: 33084007 Free article.

9

Oxidative stress and DNA damage in patients with migraine.

Geyik S, Altunısık E, Neyal AM, Taysi S. Geyik S, et al. Among authors: altunisik e. J Headache Pain. 2016;17:10. doi: 10.1186/s10194-016-0606-0. Epub 2016 Feb 17. J Headache Pain. 2016. PMID: 26883365 Free PMC article.

10

Content and quality analysis of videos about multiple sclerosis on social media: The case of YouTube.

Altunisik E, Firat YE, Kiyak Keceli Y. Altunisik E, et al. Mult Scler Relat Disord. 2022 Sep;65:104024. doi: 10.1016/j.msard.2022.104024. Epub 2022 Jul 6. Mult Scler Relat Disord. 2022. PMID: 35841755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results